Efficacy of nutritional pharmacology in surgical patients

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 1, Issue 1, 1998, Pages 41-50

  Lin, Edward ^a   Goncalves, John A ^b   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARENA;

AMINO ACID; HUMAN GROWTH HORMONE; LIPID; NUCLEOTIDE; SOMATOMEDIN C;

CLINICAL TRIAL; ENTERIC FEEDING; HUMAN; NUTRITION; NUTRITIONAL SUPPORT; PHYSIOLOGY; POSTOPERATIVE CARE; REVIEW; TOTAL PARENTERAL NUTRITION;

AMINO ACIDS; CLINICAL TRIALS; ENTERAL NUTRITION; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; NUCLEOTIDES; NUTRITION PHYSIOLOGY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION, TOTAL; POSTOPERATIVE CARE;

EID: 0031598282     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-199801000-00008     Document Type: Article

References (118)

1. Daley BJ, Caghill S, Driscoll DF, Bistrian BR. Parenteral and enteral nutrition. In: Gastrointestinal pharmacotherapy. Wolfe MM (editor). Philadelphia: WB Saunders; 1996. pp. 293-316.
2. Jeevanandam M, Legaspi A, Lowry SF, Horowitz GD, Brennan MF. Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease. J Parent Ent Nutr 1988; 12:229-236.
3. Lin E, Galvano SE, Lowry SF. Cytokine response in abdominal surgery. In: Cytokines and the abdominal surgeon. Schein M, Wise L (editors) Landes: Austin; 1988.
4. Katz JA, Lowry SF. Substrate utilization in hypermetabolism. In: Sepsis and multiorgan failure. Fein AM, Abraham E, Balk R, Bernard G, Dantzker D, Fink M (editors). Philadelphia: Williams & Wilkins, 1997.
5. Lowry SF, Thompson WA. Nutrient modification of inflammatory mediator production. New Horizons 1994; 2:164-174.
6. Mowat AM, Viney JL. The anatomical basis of intestinal immunity. Immunol Rev 1997; 156:145-166. An excellent review of the microanatomical and functional components of the intestinal barrier. References are very comprehensive.
7. Fong Y, Marano MA, Barber A, He W, Moldawer LL, Bushman ED, et al. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 1989; 210:449-457.
8. Lowry SF. The route of feeding influences injury responses. J Trauma 1990; 30:S10-S15.
9. Ogle CK, Guo X, Hasselgren PO, Ogle JD, Alexander JW. The gut as a source of inflammatory cytokines after stimulation with endotoxin. Eur J Surg 1997; 163:45-41.
10. Buchman AL, Moukarzel AA, Bhuta S, Belle M, Ament ME, Eckhert CD, et al. Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. J Parent Ent Nutr 1995; 19:453-460.
11. Hadfield RJ, Sinclair DG, Houldsworth PE, Evans TW. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995; 152:1545-1548.
12. Bengmark S, Jeppsson B. Gastrointestinal surface protection and mucosa reconditioning. J Parent Ent Nutr 1995; 19:410-415.
13. Langkamp-Henken B, Donovan TB, Pate LM, Maull CD, Kudsk KA. Increased intestinal permeability following blunt and penetrating trauma. Crit Care Med 1995; 23:660-664.
14. Pearlstone DB, Lee JI, Alexander RH, Chang TH, Brennan MF, Burt M. Effect of enteral and parenteral nutrition on amino acid levels in cancer patients. J Parent Ent Nutr 1995; 19:204-208.
15. Harrison LE, Hochwald SN, Heslin MJ, German R, Burt M, Brennan MF. Early postoperative enteral nutrition improves peripheral protein kinetics in upper gastrointestinal cancer patients undergoing complete resection: a randomized trial. J Parent Ent Nutr 1997; 21:202-207.
16. Reynolds JV, Kanwar S, Welsh FKS, Windsor ACJ, Murchan P, Barclay GR, et al. Does the route of feeding modify gut barrier function and clinical outcome in patients after major upper gastrointestinal surgery? J Parent Ent Nutr 1997; 21:196-201. Reappraises the influence of feeding route on intestinal barrier function. Despite our own biases, enteral feeding may not be any more beneficial than parenteral feeding.
17. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal trauma - reduced septic morbidity. J Trauma 1989; 29:916-922.
18. Kudsk KA. Gut mucosal nutritional support - enteral nutrition as primary therapy after multiple system trauma. Gut 1994; 1:S52-S54.
19. Jenkins ME, Gottschlich MM, Warden GD. Enteral feeding during operative procedures in thermal injuries. J Burn Care Rehab 1994; 1:199-205.
20. Bergstrom J, Furst P, Noreee LO, Vinnars E. Intracellular free amino acid concentration in human muscle tissue. J Appl Physiol 1974; 36:693-696.
21. Hartmann F, Plauth M. Intestinal glutamine metabolism. Metabolism 1989; 38:S18-S24.
22. Souba WW. Cytokine control of nutrition and metabolism in critical illness. Curr Probl Surg 1994; 31:577-652.
23. Tamada H, Nezu R, Matsuo Y, Imamura I, Takagi Y, Okada A. Alanyl glutamine-enriched total parenteral nutrition restores intestinal adaptation after either proximal or distal massive resection in rats. J Parent Ent Nutr 1993; 17:236-242.
24. Barber AE, Jones WG, Minei JP, Fahey TJ, Moldawer LL, Rayburn JL, et al. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin. J Parent Ent Nutr 1990; 14:335-343.
25. Foitzik T, Stufler M, Hotz HG, Klinnert J, Wagner J, Warshaw AL, et al. Glutamine stabilizes intestinal permeability and reduces pancreatic infection in acute experimental pancreatitis. J Gastrointest Surg 1997; 1:40-47.
26. Babst R, Horig H, Stehle P, Brand O, Filgueira L, Marti W, et al. Glutamine peptide-supplemented long-term total parenteral nutrition: effects on intracellular and extracellular amino acid patterns, nitrogen economy, and tissue morphology in growing rats. J Parent Ent Nutr 1993; 17:566-574.
27. Yamaguchi T, Minor T, Isselhard W. Effect of glutamine or glucagon-insulin enriched total parenteral nutrition on liver and gut in 70% hepatectomized rats with colon stenosis. J Am Coll Surg 1997; 185:156-162.
28. Li J, Kudsk KA, Janu P, Renegar KB. Effect of glutamine-enriched total parenteral nutrition on small intestinal gut-associated lymphoid tissue and upper respiratory tract immunity. Surgery 1997; 121:542-549.
29. Houdijk AP, Teerlink T, Bloemers FW, Wesdorp RI, van Leeuwen PA. Gut endotoxin restriction prevents catabolic changes in glutamine metabolism after surgery in the bile duct-ligated rat. Ann Surg 1997; 225:391-400.
30. Gennari R, Alexander JW. Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis. Crit Care Med 1997; 25:1207-1214.
31. Furukawa S, Saito H, Inaba T, Lin MT, Inoue T, Naka S, et al. Glutamine-enriched enteral diet enhances bacterial clearance in protracted bacterial peritonitis, regardless of glutamine form. J Parent Ent Nutr 1997; 21:208-214.
32. Klimberg VS, Souba WW, Dolson DJ. Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer 1990; 66:62-68.
33. Klimberg VS, Pappas AA, Nwokedi E, Jensen JC, Broadwater JR, Lang NP, et al. Effect of supplemental dietary glutamine on methotrexate concentrations in tumors. Arch Surg 1992; 127:1317-1320.
34. Klimberg VS, McClellan JL. Glutamine, cancer, and its therapy. Am J Surg 1996; 172:418-424.
35. Alverdy JC. Effect of glutamine-supplemented diets on immunology of the gut. J Parent Ent Nutr 1990; 4:S109-S113.
36. Horig H, Spagnoli GC, Filgueira L, Babst R, Gallati H, Harder F, et al. Exogenous glutamine requirements is confined to late events of T cell activation. J Cell Biochem 1993; 53:343-351.
37. Van der Hulst RRWJ, von Meyenfeldt MF, Deutz NEP, Soeters PB. Glutamine extraction by the gut is reduced in patients with depleted gastrointestinal cancer. Ann Surg 1997; 225:112-121. Highlights the complexities of glutamine extraction in humans. Tumors once thought to be a universal glutamine trap may not be the primary source of systemic glutamine depletion.
38. Byrne TA, Morrissey TB, Natttakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. J Parent Ent Nutr 1995; 19:296-302.
39. Byrne TA, Persinger RL, Young LS, Ziegler TR, Wilmore DW. A new treatment for patients with short-bowel syndrome. Ann Surg 1995; 222:243-255.
40. Scheltinga MR, Young LS, Benfell K, Bye RL, Ziegler TR, Santos AA, et al. Glutamine-enriched intravenous feedings attenuate extracellular fluid expansion after a standard stress. Ann Surg 1991; 214:385-395.
41. Ziegler TR, Young LS, Benfell K, Scheltinga M, Hortos K, Bye R, et al. Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 1992; 116:821-828.
42. Schloerb PR, Amare M. Total parenteral nutrition with glutamine in bone marrow transplantation and other clinical applications. J Parent Ent Nufr 1983; 17:407-413.
43. Griffiths RD, Jones C, Palmer TEA. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition 1997; 13:295-302.
44. Long CL, Nelson KM, DiRienzo DB, Weis JK, Stahl RD, Broussard TD, et al. Glutamine supplementation of enteral nutrition: impact on whole body protein kinetics and glucose metabolism in critically ill patients. J Parent Ent Nutr 1995; 19:470-476.
45. Braxton CC, Coyle SM, van der Poll T, Roth M, Galvano SE, Lowry SF. Influence of glutamine-supplemented TPN on in vitro and in vivo responses to endotoxin. Surg Forum 1995; 46:21-23.
46. Barbul A. Arginine: biochemistry, physiology, and therapeutic implications. J Parent Ent Nutr 1986; 10:227-238.
47. Saito H, Trocki O, Wang SL, Gonce SJ, Joffe SN, Alexander JW. Metabolic and immune effects of dietary arginine supplementation after burn. Arch Surg 1987; 122:784-789.
48. Nirgiotis JG, Hennessey PJ, Andrassy RJ. The effects of an arginine-free enteral diet on wound healing and immune function in the postsurgical rat. J Ped Surg 1991; 26:936-941.
49. Shiraishi M, Hiroyasu S, Nagahama M, Miyaguni T, Higa T, Tomori H, et al. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury. J Surg Res 1997; 69:429-434.
50. Adjei AA, Yamauchi K, Nakasone Y, Konishi M, Yamamoto S. Arginine-supplemented diets inhibit endotoxin-induced bacterial translocation in mice. Nutrition 1995; 11:371-374.
51. Edwards PD, Topping D, Kontaridis MI, Moldawer LL, Copeland EM, Lind DS. Arginine-enhanced enteral nutrition augments the growth of a nitric oxide-producing tumor. J Parent Ent Nutr 1997; 21:215-219.
52. Barbul A, Lazarou SA, Efron DT, Wasserkrug HL, Efron G. Arginine enhances wound healing and lymphocyte response in humans. Surgery 1990; 108:331-337.
53. Wiebke EA, Grieshop NA, Sidner RA, Howard TJ, Yang S. Effects of L-arginine supplementation on human lymphocyte proliferation in response to nonspecific and alloantigenic stimulation. J Surg Res 1997; 70:89-94.
54. Brittenden J, Heys SD, Miller I, Sarkar TK, Hutcheon AW, Needham G, et al.. Dietary supplementation with L-arginine in patients with breast cancer (>4 cm) receiving multimodality treatment: report of a feasibility study. Br J Cancer 1994; 69:918-921.
55. Brittenden J, Heys SD, Ross J, Park KGM, Eremin O. Nutritional pharmacology: effects of L-arginine on host defenses, response to trauma and tumour growth. Clin Sci 1994; 86:123-132.
56. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis, and immunity. J Parent Ent Nutr 1990; 24:S226-S229.
57. Beaumier L, Castillo L, Ajami AM, Young VR. Urea cycle intermediate kinetics and nitrate excretion at normal and therapeutic intakes of arginine in humans. Endocrinol Metab 1995; 32:E884-E896.
58. Zhong Z, Jones S, Thruman RG. Glycine minimized reperfusion injury in a low-flow, reflow liver perfusion model in the rat. Am J Physiol 1996; 270:G332-G338.
59. Wetzels JFM, Wang X, Gengaro PE, Nemenoff RA, Burke TJ, Schrier RW. Glycine protection against hypoxic but not phospholipase A2-induced injury in rat proximal tubules. Am J Physiol 1993; 264:F94-F99.
60. Iijima S, Shou J, Naama H, Galvano SE, Daly JM. Beneficial effect of enteral glycine in intestinal ischemia/reperfusion injury. J Gastrointest Surg 1997; 1:61-68.
61. Milei J, Ferreira R, Llesuy S, Forcada P, Covarrubias J, Boveris A. Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am Heart J 1992; 123:339-345.
62. Park E, Schuller-Levis G, Quinn MR. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J Immunol 1995; 154:4778-4784.
63. Redmond HP, Wang JH, Bouchier-Hayes D. Taurine attenuates nitric oxide- and reactive oxygen intermediate-dependent hepatocyte injury. Arch Surg 1996; 131:1280-1288.
64. O'Flaherty L, Stapleton PP, Redmond HP, Bouchier-Hayes D. Dexamethasone and lipopolysaccharide regulation of taurine transport in Caco-2 cells. J Surg Res 1997; 69:331-336.
65. Wang JH, Redmond HP, Watson RWG, Condron C, Bouchier-Hayes D. The beneficial effect of taurine on the prevention of human endothelial cell death. Shock 1996; 6:331-338.
66. Kishibuchi M, Tsujinaka T, Yano M, Morimoto T, Iijima S, Ogawa A, et al. Effects of nucleosides and a nucleotide mixture on gut mucosal barrier function on parenteral nutrition in rats. J Parent Ent Nutr 1997; 21:104-111.
67. Carver JD, Cox WI, Barness LA. Dietary nucleotide effects upon murine natural killer cell activity and macrophage activation. J Parent Ent Nutr 1990; 14:18-22.
68. Adjei AA, Takamine FT, Yokoyama H, Shiokawa K, Matsumoto Y, Asato L, et al. The effects of oral RNA and intraperitoneal nucleoside-nucleotide administration on methicillin-resistant Staphylococcus aureus infection in mice. J Parent Ent Nutr 1993; 17:148-152.
69. Van Buren CT, Rudolph FB, Kulkarni AD. Reversal of immunosuppression induced by a protein free diet: comparison of nucleotides, fish oil and arginine. Crit Care Med 1990; 18:3114-3117.
70. Youn JK, Kim BS, Min JS, Lee KS, Choi HJ, Lee YB, et al. Adjuvant treatment of operable stomach cancer with polyadenylic-polyuridylic acid in addition to chemotherapeutic agents: a preliminary report. Int J Immunopharmacol 1990; 12:289-295.
71. Lacour J, Laplanche A, Delozier T, Berlie J, Mourali N, Julien JP, et al. Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapy versus chemotherapy with CMF as adjuvants in operable breast cancer. Breast Cancer Res Treat 1991; 19:15-21.
72. Lacour J, Laplanche A, Malafosse M, Gallot D, Julien M, Rotman N, et al. Polyadenylic-polyuridylic acid as an adjuvant in resectable colorectal carcinoma: a 6 year follow-up analysis of a multicentric double blind randomized trial. Eur J Surg Oncol 1992; 18:599-604.
73. Khan AL, Richardson S, Drew J, Larsen F, Campbell M, Heys SD, et al. Polyadenylic-polyuridylic acid enhances the natural cell-mediated cytotoxicity in patients with breast cancer undergoing mastectomy. Surgery 1995; 118:531-538.
74. Gogos CA, Zoumbos N, Makri M, Kalfarentzos F. Medium- and long-chain triglycerides have different effects on the synthesis of tumor necrosis factor by human mononuclear cells in patients under total parenteral nutrition. J Am Coll Nutr 1994; 13:40-44.
75. Gogos CA, Zoumbos NC, Makri M, Kalfarentzos F. Tumor necrosis factor production by human mononuclear cells during total parenteral nutrition containing long-chain triglycerides. Nutrition 1992; 8:26-29.
76. Sedman PC, Somers SS, Ramsden CW, Brennan TG, Guillou PJ. Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition. Br J Surg 1991; 78:1396-1399.
77. Linseisen J, Wolfram G. Efficacy of different triglycerides in total parenteral nutrition for preventing atrophy of the gut in traumatized rats. J Parent Ent Nutr 1997; 21:21-26.
78. Ohkawa A, Sato N, Hatakeyama K. Effect of medium-chain triglyceride emulsion in total parenteral nutrition on experimental hepatic metastasis in the rat. J Parent Ent Nutr 1997; 21:220-223.
79. Mann KG. Thrombosis: theoretical considerations. Am J Clin Nutr 1997; 65:51657-1664.
80. Van der Poll T, Coyle SM, Levi M, Boermeester MA, Braxton CC, Jansen PM, et al. Fat emulsion infusion potentiates coagulation activation during human endotoxemia. Thromb Haemost 1996; 75:83-86. Documents important mechanisms that explain the prothrombotic potential of lipid infusion in parenteral nutrition.
81. Kinsella JE, Lokesh B. Dietary lipids, eicosanoids and the immune system. Crit Care Med 1990; 18:S94-S113.
82. Kremer JM, Jubiz W, Michalek A, Rynes RI, Bartholomew LE, Bigaouette J, et al. Fish oil fatty acid supplementation in active rheumatoid arthritis: a double-blinded, controlled, crossover study. Ann Intern Med 1987; 106:497-503.
83. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, Van der Meer JW, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320:265-271.
84. Trocki O, Heyd J, Waymack JP, Alexander JW. Effects of fish oil on postburn metabolism and immunity. J Parent Ent Nutr 1987; 11:521-528.
85. Sierra P, Ling PR, Istfan NW, Bistrian BR. Fish oil feeding improves muscle glucose uptake in tumor necrosis factor-treated rats. Metabolism 1995; 44:1365-1370.
86. Lo CJ, Terasaki M, Garcia R, Helton S. Fish oil-supplemented feeding does not attenuate warm liver ischemia and reperfusion injury in the rat. J Surg Res 1997; 71:54-60.
87. Mancuso P, Whelan J, DeMichele SJ, Snider CC, Guszcza JA, Karlstad MD. Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Crit Care Med 1997; 25:1198-1206.
88. Hughes DA, Pinder AC, Piper Z, Johnson IT, Lund EK. Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 1996; 63:267-272.
89. Kenler AS, Swails WS, Driscoll DF, DeMichele SJ, Daley B, Babineau TJ, et al. Early enteral feeding in postsurgical cancer patients: fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg 1996; 223:316-333.
90. Ziegler TR, Young LS, Ferrari-Baliviera E, Demling RH, Wilmore DW. Use of human growth hormone combined with nutritional support in a critical care unit. J Parent Ent Nutr 1990; 14:574-581.
91. Jeevanandam M, Petersen SR. Altered lipid kinetics in adjuvant recombinant human growth hormone-treated multiple-trauma patients. Endocrinol Metab 1994; 30:E560-E565.
92. Crown AL, Holly JMP. The insulin-like growth factor system in critical illness: pathophysiology and therapeutic potential. Clin Nutr 1995; 14:321-328.
93. Inaba T, Saito H, Fukushima R, Hashiguchi Y, Lin MT, Inoue T, et al. Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats. J Parent Ent Nutr 1996; 20:325-331.
94. Jeevanandam M, Holaday NJ, Petersen SR. Adjuvant recombinant human growth hormone does not augment endogenous glucose production in total parenteral nutrition-fed multiple trauma patients. Metabolism 1996; 45:450-456.
95. Lazarus DD, Moldawer LL, Lowry SF. Insulin-like growth factor-1 activity is inhibited by interleukin-1a, tumor necrosis factor-α, and interleukin-6. Lymphokine Cytokine Res 1993; 12:219-223.
96. Ng EH, Rock CS, Lazarus D, Staiano-Coico L, Fischer E, Moldawer LL, et al. Impact of exogenous growth hormone on host preservation and tumor cell-cycle distribution in a rat sarcoma model. J Surg Res 1991; 51:99-105.
97. Inaba T, Saito H, Fukushima R, Hashiguchi Y, Lin MT, Inoue T, et al. Insulin-like growth factor 1 has beneficial effects, whereas growth hormone has limited effects on postoperative protein metabolism, gut integrity, and splenic weight in rats with chronic mild liver injury. J Parent Ent Nutr 1997; 21:55-62.
98. Hinton PS, Peterson CA, Lo HC, Yang H, McCarthy D, Ney DM. Insulin-like growth factor-I enhances immune response in dexamethasone-treated or surgically stressed rats maintained with total parenteral nutrition. J Parent Ent Nutr 1995; 19:444-452.
99. Inoue T, Saito H, Fukushima R, Inaba T, Lin MT, Fukatsu K, et al. Growth hormone and insulinlike growth factor 1 enhance host defense in a murine sepsis model. Arch Surg 1995; 130:1115-1122.
100. Chen K, Okuma T, Okamura K, Tabira Y, Kaneko H, Miyauchi Y. Insulin-like growth factor-1 prevents gut atrophy and maintains intestinal integrity in septic rats. J Parent Engl Nutr 1995; 19:119-124.
101. Voerman BJ, Van Schijndel JMS, Groeneveld ABJ, deBoer H, Nauta JP, Thijs LG. Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial. Crit Care Med 1995; 23:665-673.
102. Koea JB, Breier BH, Douglas RG, Gluckman PD, Shaw JHF. Anabolic and cardiovascular effects of recombinant human growth hormone in surgical patients with sepsis. Br J Surg 1996; 83:196-202.
103. Jeevanandam M, Ali MR, Holaday NJ, Petersen SR. Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients. J Parent Ent Nutr 1995; 19:137-144.
104. Behrman SW, Kudsk KA, Brown RO, Vehe KL, Wojtysiak SL. The effect of growth hormone on nutritional markers in enterally fed immobilized trauma patients. J Parent Ent Nutr 1995; 19:41-46.
105. Ellegard L, Bosaeus I, Nordgren S, Bengtsson BA. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 1997; 225:88-96.
106. Cioffi WG, Gore DC, Rue LW, Carrougher G, Guler HP, McManus WF, et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994; 220:310-319.
107. Goeters C, Mertes N, Tacke J, Bolder U, Kuhmann M, Lawin P, et al. Repeated administration of recombinant human insulin-like growth factor-1 in patients after gastric surgery. Ann Surg 1995; 222:646-653.
108. Yarwood GD, Ross RJM, Medbak S, Coakley J, Hinds CJ. Administration of human recombinant insulin-like growth factor-1 in critically ill patients. Crit Care Med 1997; 25:1352-1361.
109. Thompson WA, Coyle SM, Lazarus D, Fisher E, Van Zee K, Rock C, et al. The metabolic effects of a continuous infusion of insulin-like growth factor (IGF-1) in parenterally fed men. Surg Forum 1991; 42:23-25.
110. Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 1995; 23:436-449.
111. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995; 221:327-333.
112. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, Rosato EF, et al. Enteral nutrition with supplemental arginine, RNA and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992; 112:56-67.
113. Kurz A, Sessler DI, Lenhardt R. Study of wound infection and temperature group: perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996; 334:1209-1215.
114. Kemen M, Senkal M, Homann HH, Mumme A, Dauphin AK, Baier J, et al. Early postoperative enteral nutrition with arginine, omega-3 fatty acids and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunological evaluation of Impact. Crit Care Med 1995; 23:652-659.
115. Kudsk KA, Minard G, Grace MA, Brown RO, Lowrey TS, Pritchard FE, et al. A randomized trial of isonitrogenous enteral diets after severe trauma: an immune-enhancing diet reduces septic complications. Ann Surg 1996; 224:531-543. Describes a well conducted clinical trial that demonstrates some benefit of immunoenhancing enteral diets in severe trauma. May serve as basis for further investigation.
116. Braga M, Gianotti L, Cestari A, Vignali A, Pellegatta F, Dolci A, et al. Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. Arch Surg 1996; 131:1257-1265.
117. Saffle JR, Wiebke G, Jennings K, Morris SE, Barton RG. Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma 1997; 42:793-600.
118. Heslin MJ, Latkany L, Leung D, Brooks AD, Hochwald SN, Pisters PWT, et al. A prospective randomized trial of early enteral feeding after resection of upper GI malignancy. Ann Surg 1997; 226:567-580. This study is free of post-hoc data analysis and was conducted in an intention-to-treat fashion. Design and conclusions are difficult to refute. Will serve as a landmark paper, clearly demonstrating no benefit for postoperative immunoenhancing enteral formulas in the surgical oncology patient.